Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2024-08-30 Regulatory Filings
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation about the company's participation in an Analysts/Investors Group meeting, pursuant to Regulation 30 of SEBI Listing Obligations. It provides details about the meeting date, venue, and mode, and mentions that the discussion will cover business overview, financial performance, and outlook. The document is a notification of an upcoming investor meeting rather than a report or transcript of the meeting itself. It does not contain financial statements, detailed presentations, or transcripts. Therefore, it fits best under the category of Investor Presentation (IP), as it relates to investor communication focusing on financials and strategy, even though it is an intimation of participation rather than the presentation itself. However, since it is only an intimation of participation and not the presentation material, and given the document length is short and it is an announcement, the correct classification is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-08-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 85% confidence The document is an intimation of the company's participation in an Analysts/Investors Group meeting, pursuant to Regulation 30 of SEBI Listing Obligations. It mentions the date, venue, and mode of the meeting and states that the discussion will cover business overview, financial performance, and outlook. There is no detailed financial data, no full report, no earnings release, or any other comprehensive report content. The document is short (2252 characters) and serves as a notification of an upcoming investor presentation meeting rather than the presentation itself. Therefore, it fits best under Investor Presentation (IP) category as it relates to investor communication focusing on financials and strategy, even though it is an intimation of participation rather than the presentation document itself. Given the nature and content, confidence is high but not absolute since it is an intimation rather than the presentation itself.
2024-08-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the company's participation in an upcoming Analysts/Investors Group meeting. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events and information. The content focuses on informing the exchanges about the meeting date, mode, and topics to be discussed (business overview, financial performance, and outlook). There is no actual financial data, report, or detailed presentation included in the text. The document is short (2158 characters) and serves as an announcement of an event rather than a report or transcript. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to a meeting where such a presentation will be made, but since the document itself is only an intimation of participation and not the presentation material, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory disclosure about an event rather than the presentation itself or a transcript.
2024-08-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is titled 'Q1 & FY25 - Earnings Conference Call Transcript' and contains a detailed transcript of the company's earnings conference call held on August 8, 2024. It includes management's opening remarks, financial highlights, and a Q&A session with analysts and investors. The content focuses on quarterly financial performance, business updates, and strategic outlook, which is characteristic of an earnings call transcript. There is no indication that this is a presentation, regulatory filing, or a full financial report like an annual or interim report. Therefore, the document fits the category of a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains the full transcript, not just an announcement or summary, supporting a high confidence level.
2024-08-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled 'Q1 FY25 Earnings Presentation' and includes detailed sections such as financial performance, business overview, leadership team, manufacturing infrastructure, and R&D capabilities. It is a presentation format, typically used to communicate quarterly financial results and strategic updates to investors. The presence of forward-looking statements and a table of contents further supports this. The document length is substantial (15,000 characters), indicating it is the full presentation rather than a brief announcement. Therefore, this document fits the category of an Investor Presentation (IP).
2024-08-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the outcome of an Analysts/Investors Conference Call. It provides a link to the audio recording of the call but does not contain the transcript or detailed financial data. The document is only 1546 characters long and serves as a notification rather than the full transcript or report. According to the rules, such announcements about conference calls without the full transcript should be classified as Regulatory Filings (RNS) because it is a general regulatory announcement and does not contain the full call transcript or substantive financial data.
2024-08-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.